Previous Close | 0.7700 |
Open | 0.7200 |
Bid | 0.7000 |
Ask | 0.7300 |
Strike | 60.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.7200 - 0.7200 |
Contract Range | N/A |
Volume | |
Open Interest | 1.07k |
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.